Cas:15118-67-9 Ethyl 3-(4-methoxybenzoyl)propionate manufacturer & supplier

Chemical Name:Ethyl 3-(4-methoxybenzoyl)propionate

CAS.NO:15118-67-9

Synonyms:Ethyl 3-(4-methoxybenzoyl)propionate;ethyl 3-(4-methoxybenzoyl)propanoate;Ethyl 4-(4-methoxyphenyl)-4-oxobutyrate;4-(4-methoxyphenyl)-4-oxobutyric acid ethyl ester;MFCD00051784;ethyl (4-methoxyphenyl)-4-oxobutanoate;ethyl 3-(p-methoxybenzoyl)propanoate

Molecular Formula:C₁₃H₁₆O₄

Molecular Weight:236.26400

HS Code:2918990090

Physical and Chemical Properties:

Melting point:50-54ºC(lit.)

Boiling point:365ºC at 760mmHg

Density:1.101g/cm3

Index of Refraction:1.501

PSA:52.60000

Exact Mass:236.10500

LogP:2.22120

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl 3-(4-methoxybenzoyl)propionate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 3-(p-methoxybenzoyl)propanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 4-(4-methoxyphenyl)-4-oxobutyrate Use and application,ethyl 3-(4-methoxybenzoyl)propanoate technical grade,usp/ep/jp grade.

Related News: If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. Ethyl 3-(4-methoxybenzoyl)propionate manufacturer Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. Ethyl 3-(4-methoxybenzoyl)propionate supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. Ethyl 3-(4-methoxybenzoyl)propionate vendor If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. Ethyl 3-(4-methoxybenzoyl)propionate factory If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said.